250 related articles for article (PubMed ID: 21757886)
1. Successful treatment of autoimmune hemolytic anemia associated with multicentric Castleman disease by anti-interleukin-6 receptor antibody (tocilizumab) therapy.
Yuzuriha A; Saitoh T; Koiso H; Mitsui T; Uchiumi H; Yokohama A; Handa H; Kojima M; Tsukamoto N; Karaswa M; Murakami H; Nojima Y
Acta Haematol; 2011; 126(3):147-50. PubMed ID: 21757886
[TBL] [Abstract][Full Text] [Related]
2. [Evans syndrome complicated with multicentric Castleman disease successfully treated with tocilizumab].
Nakayama H; Kikuchi T; Abe R; Tozawa K; Watanuki S; Shimizu T; Mitsuhashi T; Murata M; Okamoto S; Mori T
Rinsho Ketsueki; 2018; 59(8):997-1001. PubMed ID: 30185717
[TBL] [Abstract][Full Text] [Related]
3. [Autoimmune hemolytic anemia associated with multicentric Castleman's disease with a 28-year history].
Hisatake J; Ishiyama T; Akimoto Y; Matsuda I; Hino K; Tomoyasu S; Tsuruoka N; Ota H; Kazama K
Rinsho Ketsueki; 1994 Aug; 35(8):768-73. PubMed ID: 7933564
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab.
Tabata S; Higuchi T; Tatsukawa S; Narimatsu K; Takeo H; Matsukuma S; Ito T
Intern Med; 2019 Nov; 58(22):3313-3318. PubMed ID: 31292389
[TBL] [Abstract][Full Text] [Related]
5. Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody.
Kanda J; Kawabata H; Yamaji Y; Ichinohe T; Ishikawa T; Tamura T; Furukawa Y; Kimura T; Kita T; Uchiyama T
Int J Hematol; 2007 Apr; 85(3):207-11. PubMed ID: 17483056
[TBL] [Abstract][Full Text] [Related]
6. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
Matsuyama M; Suzuki T; Tsuboi H; Ito S; Mamura M; Goto D; Matsumoto I; Tsutsumi A; Sumida T
Intern Med; 2007; 46(11):771-4. PubMed ID: 17541233
[TBL] [Abstract][Full Text] [Related]
7. Humanized anti-interleukin 6 receptor antibody induced long-term remission in a patient with life-threatening refractory autoimmune hemolytic anemia.
Kunitomi A; Konaka Y; Yagita M; Nishimoto N; Kishimoto T; Takatsuki K
Int J Hematol; 2004 Oct; 80(3):246-9. PubMed ID: 15540899
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.
Song SN; Tomosugi N; Kawabata H; Ishikawa T; Nishikawa T; Yoshizaki K
Blood; 2010 Nov; 116(18):3627-34. PubMed ID: 20644113
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
[TBL] [Abstract][Full Text] [Related]
10. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
11. [Long-term treatment with a humanized anti-interleukin-6 receptor antibody (tocilizumab), improving interstitial pneumonia in a patient with multicentric Castleman disease].
Harada N; Sayama K; Tanaka K; Hasegawa N; Okamoto S; Hayashi Y; Ishizaka A
Nihon Kokyuki Gakkai Zasshi; 2010 Feb; 48(2):145-50. PubMed ID: 20184247
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of long term administration of humanized anti-interleukin-6 receptor antibody (tocilizumab) for multicentric Castleman's disease with pulmonary involvement].
Akahane D; Kimura Y; Sumi M; Sashida G; Gotoh A; Miyazawa K; Ohyashiki K
Rinsho Ketsueki; 2006 Aug; 47(8):748-52. PubMed ID: 16986713
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune hemolytic anemia in a patient with idiopathic interstitial pneumonia].
Fukuda K; Yokoyama Y; Kamada Y; Taoka K; Suzukawa K; Chiba S
Rinsho Ketsueki; 2011 Jan; 52(1):14-7. PubMed ID: 21378476
[TBL] [Abstract][Full Text] [Related]
14. [Autoimmune hemolytic anemia with eosinophilia in elderly patient].
Tamura J; Jinbo T; Murata N; Itoh K; Murakami H; Take H; Tamura K; Kurabayashi H; Kubota K; Shirakura T
Nihon Ronen Igakkai Zasshi; 1996 Aug; 33(8):603-6. PubMed ID: 8921699
[TBL] [Abstract][Full Text] [Related]
15. [Sarcoidosis in a patient with autoimmune hemolytic anemia].
Yasuda N; Kohda M; Nomura M; Nagashima K; Takemura G; Takatsu H; Minatoguchi S; Gotoh K; Fujiwara H
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Aug; 34(8):931-6. PubMed ID: 8965407
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
Ocio EM; Sanchez-Guijo FM; Diez-Campelo M; Castilla C; Blanco OJ; Caballero D; San Miguel JF
Am J Hematol; 2005 Apr; 78(4):302-5. PubMed ID: 15795923
[TBL] [Abstract][Full Text] [Related]
17. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
18. Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases.
Nagao A; Nakazawa S; Hanabusa H
J Hematol Oncol; 2014 Jan; 7():10. PubMed ID: 24438824
[TBL] [Abstract][Full Text] [Related]
19. Pure red cell aplasia accompanied by autoimmune hemolytic anemia in a patient with type A viral hepatitis.
Koiso H; Kobayashi S; Ueki K; Hamada T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
Rinsho Ketsueki; 2009 May; 50(5):424-9. PubMed ID: 19483404
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report.
Sugawara E; Sato T; Amasaki Y; Katsumata K
Medicine (Baltimore); 2022 Feb; 101(8):e28941. PubMed ID: 35212301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
